A co-occurring disorder is one that involves both substance misuse and another mental health illness such as depression, anxiety, or bipolar disorder. Both disorders combined present a special challenge for patients, and they require a comprehensive treatment approach by professionals trying to help. SAMHSA published a recent article highlighting the prevalence of people in America

Historically, abstinence-based recovery has sought to establish that recovering addicts abstain from all use of illicit substances including alcohol. This model of treatment was originally rooted in the Alcoholics Anonymous 12 Step Program which by design was intended to address alcohol addiction specifically. That program has been extremely popular and effective in helping alcohol dependent

An overview: Methadone and Suboxone are the two leading medications used in the treatment of opioid addiction. Methadone has been utilized in opioid treatment in the United States since the late 1960’s. Suboxone was introduced in 2002. Methadone and suboxone are in widespread use around the world due to their proven benefit in the treatment

Joe McDonald is President and CEO of Catholic Health Services in Buffalo, NY. They are an outpatient substance abuse treatment facility who recently relocated, and are adding “medication-assisted treatment” to help local people struggling with opioid addiction. Joe wrote an opinion piece for The Buffalo News, and in it expressed his hope that the local

SAMHSA published an article on their website referencing data collected from 40 million Blue Cross Blue Shield subscribers. The article stated that Substance Use and Mental Health Disorders have a negative effect on Americans’ longevity, productivity, and general health. Specifically, depression, anxiety, and mood disorders were cited as having the greatest impact on health. Substance

Last month, the President and CEO of Partnership for Drug-Free Kids sent President Trump a letter requesting special funding to address the national opioid addiction & overdose crisis. Marcia Lee Taylor asked that the Trump Administration make this problem a priority and work with educators, healthcare providers, and governmental officials to draft policy solutions that

The Pew Charitable Trusts published a video overview on medication-assisted therapy for opioid use disorder. The clip is less than 2 minutes (shown below), and offers a quick summary of the medications often used in treating opioid addiction. Opioid use disorder is highlighted as a complex brain disease. Medication-Assisted Treatment (MAT) combines medication + behavioral

Advocates For Opioid Recovery is a non-profit organization spearheaded by Newt Gingrich, Patrick Kennedy, and Van Jones. The group is dedicated to advancing evidence-based treatment to better address the effects of America’s opioid addiction dilemma. A main focus of the organization is breaking down regulatory barriers that exist in patient access to recovery medications like

In recognition of the 27th Annual National Recovery Month, Alcohol & Drug Services, Inc. and Caring Services, Inc. will sponsor CELEBRATE RECOVERY on Sunday—September 25, 2016 at Oak Hollow Festival Park (1841 Eastchester Drive, High Point, NC) from 2pm-5pm. The purpose of this event is to honor and support individuals and families who are in

Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The